Skip to main content

Alphabet Inc.

SEC CIK
0001652044
Latest filing
Aug 6, 2026

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Nov 15, 2022. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
36
+4 vs. Q1 2021
Portfolio value
$4.91B
+$2.43B (+97.9%) vs. Q1 2021
Filed
Nov 15, 2022
SEC
Holdings of Alphabet Inc. in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PATHUiPath, Inc.Stock29,025,785$1.97B40.2%+29,025,785NewHistory
VERVVerve Therapeutics, Inc.COM10,974,011$661.2M13.5%+10,974,011NewHistory
OSCROscar Health, Inc.CL A24,042,864$516.9M10.5%00.0%UnchangedHistory
LYFTLyft, Inc.CL A COM6,138,154$371.2M7.6%−282,831−4.4%ReducedHistory
DXCMDexcom IncCOM805,681$344.0M7.0%00.0%UnchangedHistory
DMDesktop Metal, Inc.COM CL A11,048,730$127.1M2.6%−3,253,708−22.7%ReducedHistory
RCUSArcus Biosciences, Inc.COM4,613,818$126.7M2.6%−109,530−2.3%ReducedHistory
LYELLyell Immunopharma, Inc.COM5,865,125$95.3M1.9%+5,865,125NewHistory
BEAMBeam Therapeutics Inc.COM635,586$81.8M1.7%−5,206−0.8%ReducedHistory
ABNBAirbnb, Inc.Stock525,626$80.5M1.6%−165,986−24.0%ReducedHistory
RLAYRelay Therapeutics, Inc.COM1,826,876$66.8M1.4%+258,390+16.5%AddedHistory
WORKSlack Technologies, Inc.COM CL A1,299,771$57.6M1.2%00.0%UnchangedHistory
SANASana Biotechnology, Inc.COM2,812,500$55.3M1.1%00.0%UnchangedHistory
CLOVClover Health Investments, Corp.COM CL A4,113,742$54.8M1.1%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM1,438,232$34.4M0.7%00.0%UnchangedHistory
GLUEMonte Rosa Therapeutics, Inc.COM1,464,015$33.2M0.7%+1,464,015NewHistory
DNTHDianthus Therapeutics, Inc.COM3,339,138$32.7M0.7%00.0%UnchangedHistory
BRNSBarinthus Biotherapeutics plc.ADS1,704,444$28.6M0.6%+1,704,444NewHistory
RAPTRAPT Therapeutics, Inc.COM788,813$25.1M0.5%−42,441−5.1%ReducedHistory
OMICSingular Genomics Systems, Inc.COM646,622$17.8M0.4%+646,622NewHistory
IDYAIDEAYA Biosciences, Inc.COM753,187$15.8M0.3%00.0%UnchangedHistory
EVLOEvelo Biosciences, Inc.COM1,060,495$14.6M0.3%00.0%UnchangedHistory
DBTXDecibel Therapeutics, Inc.COM1,636,258$14.1M0.3%00.0%UnchangedHistory
TSHATaysha Gene Therapies, Inc.COM SHS640,882$13.6M0.3%00.0%UnchangedHistory
VERAVera Therapeutics, Inc.CL A944,791$12.5M0.3%+944,791NewHistory
SPROSpero Therapeutics, Inc.COM889,979$12.4M0.3%00.0%UnchangedHistory
QNCXQuince Therapeutics, Inc.COM189,122$10.0M0.2%00.0%UnchangedHistory
FULCFulcrum Therapeutics, Inc.COM678,141$7.11M0.1%00.0%UnchangedHistory
NEWRNew Relic, Inc.COM91,132$6.10M0.1%00.0%UnchangedHistory
FHTXFoghorn Therapeutics Inc.COM500,901$5.34M0.1%00.0%UnchangedHistory
AUTLAutolus Therapeutics plcSPON ADS698,262$4.64M0.1%00.0%UnchangedHistory
ALECAlector, Inc.COM175,866$3.66M0.1%00.0%UnchangedHistory
UBERUber Technologies, IncStock49,466$2.48M0.1%00.0%UnchangedHistory
SQZSQZ Biotechnologies CoCOM103,929$1.50M<0.1%−727,460−87.5%ReducedHistory
TWLOTwilio IncCL A3,776$1.49M<0.1%00.0%UnchangedHistory
SPGIS&P Global Inc.Stock592$243.0K<0.1%+592NewHistory

Sold out since Q1 2021 (4)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Alphabet Inc. sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
UPSTUpstart Holdings, Inc.COM832,423$107.3M4.3%History
OPENOpendoor Technologies Inc.COM1,250,997$26.5M1.1%History
LMNDLemonade, Inc.Stock177,698$16.5M0.7%History
CRWDCrowdStrike Holdings, Inc.Stock31,020$5.66M0.2%History